NEIGRIHMS M.D Pharmacology: Fees 2026, Course Duration, Dates, Eligibility

Ans. MD Pharmacology at NEIGRIHMS operates under a Letter of Permission (LOP) granted by the Ministry of Health and Family Welfare, Government of India. An LOP is the initial approval given to a new PG course before it receives full NMC recognition. The degree awarded is fully valid and recognised, as it is granted by the affiliating university under the oversight of NMC. Candidates should note that LOP-based seats may sometimes be subject to seat availability confirmation each year, and it is advisable to verify the current status of NMC recognition at the time of admission.

Ans. The Pharmacovigilance Programme of India (PvPI) is a national initiative by the Central Drugs Standard Control Organisation (CDSCO) to monitor the safety of medicines in India. NEIGRIHMS is a designated ADR (Adverse Drug Reaction) Monitoring Centre under PvPI, which means the Pharmacology department is actively involved in collecting, reporting, and analysing adverse drug reactions from patients at NEIGRIHMS. MD Pharmacology students get direct hands-on experience in pharmacovigilance activities, ADR reporting, and drug safety monitoring, which is a highly valued skill in both academic and industry settings.

Ans. The Department of Pharmacology at NEIGRIHMS has two student laboratories (one for clinical pharmacy and one for experimental pharmacology), modern pharmacology equipment including HPLC and NIBP instruments, a Central Animal House facility with rodents and non-rodents for academic research, and a departmental library. The department uses computer simulation software (CAL) for animal experiment simulations. The department is also working towards setting up an advanced Therapeutic Drug Monitoring (TDM) laboratory, which will further enhance research capabilities for PG students.

Ans. MD Pharmacology graduates from NEIGRIHMS can pursue careers in academic medicine as faculty in pharmacology departments, in clinical research organisations (CROs), in the pharmaceutical industry in roles such as medical affairs, drug safety, and pharmacovigilance, and in regulatory bodies like CDSCO. The DM (Doctorate of Medicine) in Clinical Pharmacology is a popular super-specialty option after MD Pharmacology. The Head of Department at NEIGRIHMS, Dr. Chayna Sarkar, holds both MD and DM qualifications, demonstrating the academic pathway available to graduates.

Ans. NEIGRIHMS offers 2 seats for MD Pharmacology per session under LOP status. Of these, 1 seat is under the All India Quota (AIQ) filled through MCC counselling, and 1 seat is for the Open North East / NEIGRIHMS pass-out category. Since Pharmacology is a non-clinical branch, it typically attracts candidates who are specifically interested in research, teaching, or the pharmaceutical industry. The competition for these 2 seats is relatively lower compared to clinical branches, but candidates still need a valid NEET PG score above the 50th percentile to be eligible.

Ans. NEIGRIHMS has a strict bond policy for all PG students, including MD Pharmacology. If a Junior Resident (PG) leaves the course before completing one year, they must pay ₹10 Lakhs to the institute. The penalty is ₹15 Lakhs for leaving during the second year, and ₹20 Lakhs for leaving during the third year without completing the course. Original certificates are retained by the institute throughout the course duration and are returned only after the bond amount is deposited. If a candidate decides not to join after counselling, they must pay ₹50,000 to get their certificates back.